Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.

Saved in:
Bibliographic Details
Title: Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.
Authors: Pilz MJ; Health Outcomes Research Unit, University Hospital of Psychiatry II, Medial University of Innsbruck, 6020, Innsbruck, Austria., Seyringer S; Department of Nuclear Medicine, Medical University of Innsbruck, 6020, Innsbruck, Austria., Nerich V; Université de Franche-Comté, CHU Besançon, INSERM, EFS-BFC, UMR 1098, Pôle Pharmacie, 25030, Besançon, France., King MT; School of Psychology, University of Sydney, Sydney, NSW, Australia., Norman R; School of Population Health, Curtin University, Perth, Australia., Gamper EM; Health Outcomes Research Unit, University Hospital of Psychiatry II, Medial University of Innsbruck, 6020, Innsbruck, Austria. eva.gamper@tirol-kliniken.at.; Department of Nuclear Medicine, Medical University of Innsbruck, 6020, Innsbruck, Austria. eva.gamper@tirol-kliniken.at.
Corporate Authors: EORTC Quality of Life Group
Source: PharmacoEconomics [Pharmacoeconomics] 2025 Aug; Vol. 43 (8), pp. 937-953. Date of Electronic Publication: 2025 Apr 27.
Publication Type: Journal Article; Validation Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-2027
DOI:10.1007/s40273-025-01501-3